Financhill
Buy
67

CRDF Quote, Financials, Valuation and Earnings

Last price:
$3.18
Seasonality move :
11.94%
Day range:
$3.09 - $3.31
52-week range:
$1.90 - $4.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
403.64x
P/B ratio:
4.38x
Volume:
1.2M
Avg. volume:
1M
1-year change:
-26.96%
Market cap:
$213.5M
Revenue:
$683K
EPS (TTM):
-$0.79

Earnings Data

Next earnings date for CRDF
Feb 26
2026
Most recent earnings per share
-$0.17
Beat by $0.04
(Nov 6/2025)
Consensus Estimate
-$0.21
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRDF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $105.6K -- -- -$0.20 --
11/06/2025 Q3 $121.4K $120K -$0.17 -$0.21 $0.04
07/29/2025 Q2 $106.3K $121K -$0.21 -$0.20 -$0.01
05/08/2025 Q1 $89.3K $109K -$0.20 -$0.19 -$0.02
02/27/2025 Q4 $94.2K $151K -$0.21 -$0.25 $0.03
11/07/2024 Q3 $70K $165K -$0.25 -$0.27 $0.02
08/08/2024 Q2 $58.8K $163K -$0.26 -$0.25 -$0.01
05/02/2024 Q1 $55K $205K -$0.22 -$0.25 $0.03
02/29/2024 Q4 $37.5K $156K -$0.21 -$0.28 $0.07
11/02/2023 Q3 -- -- -$0.22 -$0.30 $0.08
08/09/2023 Q2 -- -- -$0.25 -$0.25 $0.00
05/04/2023 Q1 -- -- -$0.25 -$0.22 -$0.03
03/02/2023 Q4 -- -- -$0.20 -$0.25 $0.05
11/03/2022 Q3 -- -- -$0.20 -$0.24 $0.04
08/04/2022 Q2 -- -- -$0.24 -- --
05/05/2022 Q1 -- -- -$0.25 -- --
02/24/2022 Q4 -- -- -$0.23 -- --
11/04/2021 Q3 -- -- -$0.17 -- --
08/05/2021 Q2 -- -- -$0.17 -- --
05/06/2021 Q1 -- -- -$0.14 -- --
02/25/2021 Q4 -- -- -$0.18 -- --
11/05/2020 Q3 -- -- -$0.19 -- --
08/11/2020 Q2 -- -- -$0.51 -- --
05/07/2020 Q1 -- -- -$0.41 -- --
12/31/2019 Q4 -- -- -$0.51 -- --
09/30/2019 Q3 -- -- -$0.69 -- --
06/30/2019 Q2 -- -- -$0.76 -- --
03/31/2019 Q1 -- -- -$1.02 -- --
12/31/2018 Q4 -- -- -$1.09 -- --
11/09/2018 Q3 -- -- -$1.10 -- --
06/30/2018 Q2 -- -- -$5.27 -- --
03/31/2018 Q1 -- -- -$6.23 -- --
02/26/2018 Q4 -- -- -$4.32 -- --
11/09/2017 Q3 -- -- -$8.46 -- --
08/09/2017 Q2 -- -- -$18.72 -- --
05/10/2017 Q1 -- -- -$23.04 -- --
03/15/2017 Q4 -- -- -$24.48 -- --
11/09/2016 Q3 -- -- -$24.48 -- --
08/04/2016 Q2 -- -- -$24.48 -- --
03/31/2016 Q1 -- -- -$25.92 -- --
12/31/2015 Q4 -- -- -$18.72 -- --

Cardiff Oncology, Inc. Earnings Questions

  • How Much did Cardiff Oncology, Inc. Generate in Revenue Last Quarter?

    Cardiff Oncology, Inc. reported $120K worth of top line sales in its most recent quarter.

  • Did Cardiff Oncology, Inc. Beat Earnings Last Quarter?

    Cardiff Oncology, Inc. announced earnings per share of -$0.17 which represents a beat of analyst forecast a -$0.21 per share.

  • Is Cardiff Oncology, Inc. Profitable?

    Cardiff Oncology, Inc. reported -$104K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Cardiff Oncology, Inc. EPS Next Year?

    Cardiff Oncology, Inc.'s earnings are forecast to decrease from -$0.95 per share to -$0.78 per share next year representing a decrease of -18.58%.

  • When is Cardiff Oncology, Inc.'s Earnings Date?

    Cardiff Oncology, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock